Endoscopic Retrograde Appendicitis Therapy
1 other identifier
interventional
20
1 country
1
Brief Summary
This is a prospective pilot study on the efficacy of endoscopic therapy for adult uncomplicated acute appendicitis. In recent years, antibiotics treatment has been a new alternative approach to surgical appendicectomy for acute appendicitis, however, there is a risk of failed antibiotics treatment and chance of recurrent appendicitis. Endoscopic therapy of acute appendicitis (ERAT) has been recently described that involves colonoscopic insertion of plastic stent and removal of appendicolith. The investigators conduct this pilot study to investigate the feasibility, technical and clinical success rate of endoscopic retrograde appendicitis therapy among adult patients with uncomplicated acute appendicitis. 20 patients would be recruited for the pilot study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2020
CompletedFirst Posted
Study publicly available on registry
February 24, 2020
CompletedStudy Start
First participant enrolled
June 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedFebruary 8, 2023
February 1, 2023
1.6 years
February 20, 2020
February 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical success rate
defined as completion of both endoscopic procedures without need for surgery or complications related to acute appendicitis
30 days
Secondary Outcomes (4)
Technical success rate
30 days
Rate of recurrent acute appendicitis, up to 1 year of index attack
1 year
Rate of adverse events related to endoscopic procedures
30 days
Scale of post-operative pain
7 days
Study Arms (1)
ERAT arm
EXPERIMENTALThis is the treatment arm where endoscopic therapy of acute appendicitis would be performed
Interventions
Colonoscopy would be introduced until visualization of the appendiceal orifice. Catheter would be placed in the appendix and decompression performed. After removal of appendicolith, plastic stent would be placed for drainage of appendix. For patients successfully treated with initial endoscopic drainage, they would be re-admitted at 1 weeks after index procedure for repeat colonoscopy. After reaching the appendiceal orifice, the previous plastic stent would be removed. A contrast appendicogram would be repeated by introducing a wire-guided catheter in the appendix, and any residual fecalith would be removed. Finally, a repeat contrast appendicogram would be performed to confirm complete clearance of fecalith.
Eligibility Criteria
You may qualify if:
- Adult patients emergency admitted for suspected acute appendicitis
- Age 18 - 70
- Computed Tomography of the abdomen with contrast confirmed uncomplicated appendicitis, as evidenced by presence of a dilated, thickened wall appendix without perforation, abscess or gangrene.
You may not qualify if:
- History of previous appendicitis
- Evidence of perforation, abscess or gangrene of appendix on CT scan
- Significant paralytic ileus as evidenced by dilated bowel loops on imaging
- Evidence of co-existing acute surgical pathologies on the CT scan
- Allergic to bowel preparation solution (Polyethylene glycol)
- Marked electrolyte abnormalities, significant renal impairment (CrCl \<30ml/min)
- Coagulopathy (INR \>1.5, platelet \<50)
- Pregnancy, or contraindication to fluoroscopy
- Other cases deemed by the examining physician as unsuitable for safe treatment
- Refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Chinese University of Hong Kong
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Consultant
Study Record Dates
First Submitted
February 20, 2020
First Posted
February 24, 2020
Study Start
June 1, 2020
Primary Completion
December 31, 2021
Study Completion
December 31, 2022
Last Updated
February 8, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share